These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

74 related items for PubMed ID: 7788551

  • 1. [Detection of c-myc translocation in human lung cancer cells by fluorescence in situ hybridization (FISH)].
    Lu Y, Cheng S, Guo S.
    Zhonghua Yi Xue Za Zhi; 1995 Apr; 75(4):214-5, 255. PubMed ID: 7788551
    [Abstract] [Full Text] [Related]

  • 2. [C-myc activation by translocation in human primary non-small cell lung cancer].
    Lu Y, Cheng S, Guo S.
    Zhonghua Yi Xue Za Zhi; 1996 Apr; 76(4):275-7. PubMed ID: 8758273
    [Abstract] [Full Text] [Related]

  • 3. Relations of the c-myc gene and chromosome 8 in non-small cell lung cancer: analysis by fluorescence in situ hybridization.
    Kubokura H, Tenjin T, Akiyama H, Koizumi K, Nishimura H, Yamamoto M, Tanaka S.
    Ann Thorac Cardiovasc Surg; 2001 Aug; 7(4):197-203. PubMed ID: 11578259
    [Abstract] [Full Text] [Related]

  • 4. Immunohistochemistry, in situ hybridization and polymerase chain reaction (PCR) in detecting c-myc expression in human malignancies.
    Tervahauta AI, Syrjänen SM, Kallio PJ, Syrjänen KJ.
    Anticancer Res; 1992 Aug; 12(3):1005-11. PubMed ID: 1622111
    [Abstract] [Full Text] [Related]

  • 5. Aneuploidy of chromosome 8 and C-MYC amplification in individuals from northern Brazil with gastric adenocarcinoma.
    Calcagno DQ, Leal MF, Taken SS, Assumpção PP, Demachki S, Smith Mde A, Burbano RR.
    Anticancer Res; 2005 Aug; 25(6B):4069-74. PubMed ID: 16309200
    [Abstract] [Full Text] [Related]

  • 6. Fluorescent in situ hybridization study of c-myc oncogene copy number in prostate cancer.
    Mark HF, Samy M, Santoro K, Mark S, Feldman D.
    Exp Mol Pathol; 2000 Feb; 68(1):65-9. PubMed ID: 10640455
    [Abstract] [Full Text] [Related]

  • 7. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB, Qian J, Lieber MM, Bostwick DG.
    Cancer Res; 1997 Feb 01; 57(3):524-31. PubMed ID: 9012485
    [Abstract] [Full Text] [Related]

  • 8. Amplification of the N-myc oncogene in an adenocarcinoma cell line of the lung.
    Kashii T, Mizushima Y, Nakagawa K, Monno S, Yano S.
    Anticancer Res; 1992 Feb 01; 12(3):621-4. PubMed ID: 1622116
    [Abstract] [Full Text] [Related]

  • 9. Relationship of p53 alteration and myc family gene overexpression with the clinical characteristics of lung cancer.
    Bai L, Sun Y, Li S.
    Chin Med J (Engl); 1997 Apr 01; 110(4):250-4. PubMed ID: 9594222
    [Abstract] [Full Text] [Related]

  • 10. Topological organization of the MYC/IGK locus in Burkitt's lymphoma cells assessed by nuclear halo preparations.
    Rätsch A, Joos S, Kioschis P, Lichter P.
    Exp Cell Res; 2002 Feb 01; 273(1):12-20. PubMed ID: 11795942
    [Abstract] [Full Text] [Related]

  • 11. [Chromosome marker--2q- during carcinogenesis and development of human lung cancer].
    Lü Y, Dong X, Guo S.
    Zhonghua Zhong Liu Za Zhi; 1997 May 01; 19(3):180-3. PubMed ID: 10920891
    [Abstract] [Full Text] [Related]

  • 12. Amplification of the N-myc oncogene in an adenocarcinoma of the lung.
    Saksela K, Bergh J, Nilsson K.
    J Cell Biochem; 1986 May 01; 31(4):297-304. PubMed ID: 3020069
    [Abstract] [Full Text] [Related]

  • 13. Detection of chromosomal anomalies and c-myc gene amplification in the cribriform pattern of prostatic intraepithelial neoplasia and carcinoma by fluorescence in situ hybridization.
    Qian J, Jenkins RB, Bostwick DG.
    Mod Pathol; 1997 Nov 01; 10(11):1113-9. PubMed ID: 9388062
    [Abstract] [Full Text] [Related]

  • 14. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ, Kohlhuber F, Mautner J, Polack A, Eick D.
    Oncogene; 1993 Jun 01; 8(6):1437-47. PubMed ID: 8502472
    [Abstract] [Full Text] [Related]

  • 15. Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.
    Persons DL, Borelli KA, Hsu PH.
    Mod Pathol; 1997 Jul 01; 10(7):720-7. PubMed ID: 9237184
    [Abstract] [Full Text] [Related]

  • 16. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A, Ozdemir M, Artan S.
    Hepatogastroenterology; 2006 Jul 01; 53(68):192-5. PubMed ID: 16608022
    [Abstract] [Full Text] [Related]

  • 17. Evidence by in situ hybridization that c-erbB-2 proto-oncogene expression is a marker of malignancy and is expressed in lung adenocarcinomas.
    Pääkkö P, Nuorva K, Kamel D, Soini Y.
    Am J Respir Cell Mol Biol; 1992 Sep 01; 7(3):325-34. PubMed ID: 1355655
    [Abstract] [Full Text] [Related]

  • 18. Co-amplification of a novel cyclophilin-like gene (PPIE) with L-myc in small cell lung cancer cell lines.
    Kim JO, Nau MM, Allikian KA, Mäkelä TP, Alitalo K, Johnson BE, Kelley MJ.
    Oncogene; 1998 Aug 27; 17(8):1019-26. PubMed ID: 9747881
    [Abstract] [Full Text] [Related]

  • 19. c-MYC activation in primary and metastatic ductal adenocarcinoma of the pancreas: incidence, mechanisms, and clinical significance.
    Schleger C, Verbeke C, Hildenbrand R, Zentgraf H, Bleyl U.
    Mod Pathol; 2002 Apr 27; 15(4):462-9. PubMed ID: 11950922
    [Abstract] [Full Text] [Related]

  • 20. Gene amplification of Myc and its coamplification with ERBB2 and EGFR in gallbladder adenocarcinoma.
    Ooi A, Suzuki S, Nakazawa K, Itakura J, Imoto I, Nakamura H, Dobashi Y.
    Anticancer Res; 2009 Jan 27; 29(1):19-26. PubMed ID: 19331129
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.